ATE501436T1 - Verfahren zur untersuchung der reaktion auf eine behandlung mit einem monoklonalen antikörper - Google Patents

Verfahren zur untersuchung der reaktion auf eine behandlung mit einem monoklonalen antikörper

Info

Publication number
ATE501436T1
ATE501436T1 AT07825673T AT07825673T ATE501436T1 AT E501436 T1 ATE501436 T1 AT E501436T1 AT 07825673 T AT07825673 T AT 07825673T AT 07825673 T AT07825673 T AT 07825673T AT E501436 T1 ATE501436 T1 AT E501436T1
Authority
AT
Austria
Prior art keywords
monoclonal antibody
cells
response
treatment
steps
Prior art date
Application number
AT07825673T
Other languages
English (en)
Inventor
Gilles Thibault
Herve Watier
Ozzo Sebastien Dall
Original Assignee
Glycode
Univ Francois Rabelais De Tours
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP06291942A external-priority patent/EP1933137A1/de
Application filed by Glycode, Univ Francois Rabelais De Tours filed Critical Glycode
Application granted granted Critical
Publication of ATE501436T1 publication Critical patent/ATE501436T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/577—Immunoassay; Biospecific binding assay; Materials therefor involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal antibodies; monoclonal antibodies per se are classified with their corresponding antigens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT07825673T 2006-09-13 2007-09-12 Verfahren zur untersuchung der reaktion auf eine behandlung mit einem monoklonalen antikörper ATE501436T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR0607990 2006-09-13
EP06291942A EP1933137A1 (de) 2006-12-15 2006-12-15 Verfahren zur Untersuchung der Reaktion auf eine Behandlung mit einem monoklonalen Antikörper
FR0700456 2007-01-23
PCT/IB2007/003498 WO2008032217A2 (fr) 2006-09-13 2007-09-12 Methode d'investigation de la reponse a un traitement par un anticorps monoclonal

Publications (1)

Publication Number Publication Date
ATE501436T1 true ATE501436T1 (de) 2011-03-15

Family

ID=39144376

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07825673T ATE501436T1 (de) 2006-09-13 2007-09-12 Verfahren zur untersuchung der reaktion auf eine behandlung mit einem monoklonalen antikörper

Country Status (5)

Country Link
US (1) US20100167315A1 (de)
EP (1) EP2062047B1 (de)
AT (1) ATE501436T1 (de)
DE (1) DE602007013068D1 (de)
WO (1) WO2008032217A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070087005A1 (en) 2005-10-14 2007-04-19 Lazar Gregory A Anti-glypican-3 antibody
BR112014018374A8 (pt) * 2012-03-02 2017-07-11 Roche Glycart Ag Método para predizer a resposta d eum paciente com câncer, kit, anticorpo, método para o tratamento do câncer e composição farmacêutica
TWI693073B (zh) 2012-12-21 2020-05-11 日商中外製藥股份有限公司 對ｇｐｃ３標的治療劑療法為有效之患者投與的ｇｐｃ３標的治療劑
WO2014114595A1 (en) * 2013-01-23 2014-07-31 Roche Glycart Ag Predictive biomarker for cancer treatment with adcc-enhanced antibodies
US11760807B2 (en) 2014-05-08 2023-09-19 Chugai Seiyaku Kabushiki Kaisha GPC3-targeting drug which is administered to patient responsive to GPC3-targeting drug therapy
EP3318879B1 (de) 2015-07-01 2020-10-21 Chugai Seiyaku Kabushiki Kaisha Verabreichung eines gegen gpc3 gerichteten therapeutikums an einen patienten mit bestätigter wirksamkeit des gegen gpc3 gerichteten therapeutikums
PT3916392T (pt) * 2016-05-30 2024-06-04 Incyte Corp Métodos para prever o benefício terapêutico da terapia anti-cd19 nos pacientes
CN111316098B (zh) 2017-09-15 2024-05-14 拜克门寇尔特公司 用于治疗的基于流动的测定
CN108663510B (zh) * 2018-04-28 2021-06-04 璞晞（广州）生物免疫技术有限公司 肝病nk细胞功能的检测评估方法及试剂盒
CN113421627B (zh) * 2021-05-11 2023-04-07 深圳市罗湖区人民医院 体外评估药物对nk细胞抗衰作用的系统

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2807767B1 (fr) * 2000-04-12 2005-01-14 Lab Francais Du Fractionnement Anticorps monoclonaux anti-d
AU2001267922A1 (en) * 2000-07-04 2002-01-14 Chugai Seiyaku Kabushiki Kaisha Method of assaying the function of fc fragment of antibody
FR2844521B1 (fr) * 2002-09-13 2004-12-24 Lab Francais Du Fractionnement Mesure de la production de cytokines comme marqueur d'activation de cellules effectrices
AU2003282161B2 (en) * 2002-09-13 2010-06-24 Laboratoire Francais Du Fractionnement Et Des Biotechnologies Cytokine production-inducing antibody
FR2844513B1 (fr) * 2002-09-13 2007-08-03 Lab Francais Du Fractionnement Anticorps pour adcc et induisant la production de cytokines.
US20080003225A1 (en) * 2006-06-29 2008-01-03 Henri Vie Method for enhancing the antibody-dependent cellular cytotoxicity (ADCC) and uses of T cells expressing CD16 receptors

Also Published As

Publication number Publication date
WO2008032217A3 (fr) 2008-06-05
US20100167315A1 (en) 2010-07-01
EP2062047A2 (de) 2009-05-27
WO2008032217A2 (fr) 2008-03-20
DE602007013068D1 (de) 2011-04-21
EP2062047B1 (de) 2011-03-09

Similar Documents

Publication Publication Date Title
ATE501436T1 (de) Verfahren zur untersuchung der reaktion auf eine behandlung mit einem monoklonalen antikörper
Ebo et al. Analyzing histamine release by flow cytometry (HistaFlow): a novel instrument to study the degranulation patterns of basophils
Valdez et al. On-demand dissolution of modular, synthetic extracellular matrix reveals local epithelial-stromal communication networks
Liu et al. Angiogenin activates Erk1/2 in human umbilical vein endothelial cells
Xue et al. Pharmacologic modulation of RORγt translates to efficacy in preclinical and translational models of psoriasis and inflammatory arthritis
Green et al. Insulin-like growth factor 1 increases apical fibronectin in blastocysts to increase blastocyst attachment to endometrial epithelial cells in vitro
Verhagen et al. Residual Type 1 Immunity in Patients Genetically Deficient for Interleukin 12 Receptor β1 (IL-12Rβ1) Evidence for an IL-12Rβ1–Independent Pathway of IL-12 Responsiveness in Human T Cells
Zhong et al. Human immune organoids to decode B cell response in healthy donors and patients with lymphoma
Zeisberg et al. Differential expression of type IV collagen isoforms in rat glomerular endothelial and mesangial cells
Seltana et al. Intestinal epithelial wound healing assay in an epithelial–mesenchymal co‐culture system
DeTemple et al. Effects of mammalian target of rapamycin inhibitors on cytokine production and differentiation in keratinocytes
Guerrini et al. N-and C-terminal modifications of nociceptin/orphanin FQ generate highly potent NOP receptor ligands
De Jesus et al. Cysteine peptidase expression in Trichomonas vaginalis isolates displaying high-and low-virulence phenotypes
Woychek et al. Nesprin‐2G knockout fibroblasts exhibit reduced migration, changes in focal adhesion composition, and reduced ability to generate traction forces
Rees et al. Inter-laboratory study of the in vitro dendritic cell migration assay for identification of contact allergens
JP2025028245A (ja) 免疫関連細胞の一次繊毛の調整方法および調整剤、試験試料の評価方法、並びに、その利用
Poillot et al. L‐type Voltage‐Gated calcium channels partly mediate Mechanotransduction in the intervertebral disc
WO2008147206A3 (en) Means and methods for classifying samples of multiple sclerosis patients
Elkington et al. A Lucilia cuprina excretory–secretory protein inhibits the early phase of lymphocyte activation and subsequent proliferation
Matsuoka et al. Skin sensitization to fluorescein isothiocyanate is enhanced by butyl paraben in a mouse model
Chen et al. Kupffer cells contribute to concanavalin A-induced hepatic injury through a Th1 but not Th17 type response-dependent pathway in mice
Liu et al. 451 Association between HLA-Cw6 status and response to guselkumab in patients with moderate to severe plaque psoriasis
CA2780932A1 (en) Assay for quantifying clostridial neurotoxin
Giner et al. Modifying RANKL/OPG mRNA expression in differentiating and growing human primary osteoblasts
Shi et al. A Stable Cell Line Co-expressing hTRPV1 and GCaMP6s: A Novel Cell-based Assay For High-throughput Screening of hTRPV1 Agonists

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties